VISID Eligibility

VISID is recruiting the following groups:

  • People aged 5 years and older who have primary immunodeficiency (inborn error of immunity) or have been on immunotherapy such as rituximab, ocrelizumab for medical conditions AND:
    1. plan to be vaccinated against COVID-19, or
    2. have received their first and/or second dose of the COVID-19 Pfizer/BioNTech or Moderna mRNA vaccination, or Astrazeneca, or
    3. were fully vaccinated against COVID-19 less than 24 weeks ago
  • Anyone aged 5 years and older who has not been vaccinated but is planning to be vaccinated against COVID-19

Please select ALL that applies to you:

 AND

It does not appear that you are eligible to participate in this study. If you believe you are eligible to participate, please contact our research coordinator